Correlation Between Reviva Pharmaceuticals and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Akari Therapeutics PLC, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Akari Therapeutics.
Diversification Opportunities for Reviva Pharmaceuticals and Akari Therapeutics
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Reviva and Akari is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Akari Therapeutics go up and down completely randomly.
Pair Corralation between Reviva Pharmaceuticals and Akari Therapeutics
Given the investment horizon of 90 days Reviva Pharmaceuticals is expected to generate 3.79 times less return on investment than Akari Therapeutics. But when comparing it to its historical volatility, Reviva Pharmaceuticals Holdings is 1.0 times less risky than Akari Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Akari Therapeutics PLC is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 98.00 in Akari Therapeutics PLC on October 26, 2024 and sell it today you would earn a total of 24.00 from holding Akari Therapeutics PLC or generate 24.49% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 94.74% |
| Values | Daily Returns |
Reviva Pharmaceuticals Holding vs. Akari Therapeutics PLC
Performance |
| Timeline |
| Reviva Pharmaceuticals |
| Akari Therapeutics PLC |
Reviva Pharmaceuticals and Akari Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Reviva Pharmaceuticals and Akari Therapeutics
The main advantage of trading using opposite Reviva Pharmaceuticals and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.| Reviva Pharmaceuticals vs. Protalix Biotherapeutics | Reviva Pharmaceuticals vs. Eyepoint Pharmaceuticals | Reviva Pharmaceuticals vs. Sellas Life Sciences | Reviva Pharmaceuticals vs. In8bio Inc |
| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |